University · founded 1963
Icahn School of Medicine at Mount Sinai
New York, United States · icahn.mssm.edu
Part of Mount Sinai Health System
- Citations, last 5 years
- 513.8k
- Works, last 5 years
- 56.9k
- h-index
- 1,324
- Scientists listed
- 2 724
- Grants since 2016
- 7 219
Grants received
2017–2020 · career development · K22
Mechanistic, prognostic, and therapeutic impact of the mitochondrial fission GTPase DRP1 in melanoma
Madhavika Niroshini Serasinghe · Icahn School of Medicine at Mount Sinai · funded by National Institutes of Health
2017–2022 · research · R01
Mechanisms of neural tube closure
Sergei Sokol · Icahn School of Medicine at Mount Sinai · funded by National Institutes of Health
2017–2022 · research · R01
Targeting Lysine Methyltransferases EZH2 and EZH1 for Treating MLL-rearranged Leukemias
Jian Jin · Icahn School of Medicine at Mount Sinai · funded by National Institutes of Health
2017–2022 · research · R01
The role of peripheral myeloid cells in Alzheimers disease
Towfique Raj · Icahn School of Medicine at Mount Sinai · funded by National Institutes of Health
2017–2022 · research · R37
Acid Sphingomyelinase and Niemann-Pick Disease
Edward H. Schuchman · Icahn School of Medicine at Mount Sinai · funded by National Institutes of Health
2017–2022 · research · R01
Cell Specificity of the Human Heroin Epigenome
Stella Dracheva · Icahn School of Medicine at Mount Sinai · funded by National Institutes of Health
2017–2018 · research · R01
Multiscale connectomic principles of resilience and susceptibility in mouse
Dani Dumitriu · Icahn School of Medicine at Mount Sinai · funded by National Institutes of Health
2017–2020 · fellowship · Scientist Development Grant
Development of human cell-based screening assays to detect subject-specific drug-response variability
Francesca Stillitano · Icahn School of Medicine at Mount Sinai · funded by American Heart Association
2017–2021 · research · RF1
Towards a comprehensive signaling pathway map of parahippocampal vulnerability in Alzheimers Disease
Vahram Haroutunian · Icahn School of Medicine at Mount Sinai · funded by National Institutes of Health
2017 · research · Pathway Accelerator Award
Central nervous system regulation of glucose metabolism
Sarah A. Stanley · Icahn School of Medicine at Mount Sinai · funded by American Diabetes Association
2017–2028 · program · P01
Stress-induced immune reprogramming in cardiovascular disease
Zahi A. Fayad · Icahn School of Medicine at Mount Sinai · funded by National Institutes of Health
2017–2024 · research · R35
PTEN and Cancer
Ramon E Parsons · Icahn School of Medicine at Mount Sinai · funded by National Institutes of Health
2017–2021 · research · R01
Mechanism of 3' exonucleolytic mRNA turnover in Bacillus subtilis
David H Bechhofer · Icahn School of Medicine at Mount Sinai · funded by National Institutes of Health
2017–2021 · research · R01
Thought disorder and social cognition in clinical risk states for schizophrenia
Cheryl Mary Corcoran · Icahn School of Medicine at Mount Sinai · funded by National Institutes of Health
2017–2021 · career development · K00
Investigation of the Role of Polycomb in Epilepsy Development and Progression
Nadia Khan · Icahn School of Medicine at Mount Sinai · funded by National Institutes of Health
2017–2021 · research · R00
Neurobehavioral Study of Warnings for Adolescents at Risk for Nicotine Dependence
An-Li Wang · Icahn School of Medicine at Mount Sinai · funded by National Institutes of Health
2017–2021 · research · R01
Harnessing Paracrine Mechanisms of Stem Cell-mediated Cardiac Contractile Enhancement
Kevin D Costa · Icahn School of Medicine at Mount Sinai · funded by National Institutes of Health
2017–2021 · research · R01
Dextran Sulfate, Beta Cell Preservation and Immune Regulation in Type 1 Diabetes
Adolfo Garcia-Ocana · Icahn School of Medicine at Mount Sinai · funded by National Institutes of Health
2017–2022 · research · R01
Cell Death Pathways and Heart Transplant Rejection
Peter Scott Heeger · Icahn School of Medicine at Mount Sinai · funded by National Institutes of Health
2017–2022 · research · R01
Role of slow waves and sleep apnea in memory and risk for Alzheimer disease
Andrew W Varga · Icahn School of Medicine at Mount Sinai · funded by National Institutes of Health
2017–2020 · fellowship · F30
Hepatitis C virus cell entry host factor requirements and mechanisms
Matthew Todd Chambers · Icahn School of Medicine at Mount Sinai · funded by National Institutes of Health
2017–2022 · research · R01
Large-scale reprogramming and expression analysis of patient-derived neural cells in schizophrenia
Kristen Jennifer Brennand · Icahn School of Medicine at Mount Sinai · funded by National Institutes of Health
2017 · grant · Patient Care
National Palliative Care Research Center Career Development Awards Program
Icahn School of Medicine at Mount Sinai · funded by Gordon and Betty Moore Foundation
2017–2021 · research · R01
Ga68-DOTATATE PET imaging of plaque inflammation
Zahi A. Fayad · Icahn School of Medicine at Mount Sinai · funded by National Institutes of Health
2017–2023 · cooperative agreement · UH3
Electrophysiological Biomarkers to Optimize DBS for Depression
Helen S Mayberg · Icahn School of Medicine at Mount Sinai · funded by National Institutes of Health
2017 · research · LRRK2 Therapeutic and Safety Initiative
Genetic and Clinical Basis for Inflammatory Bowel Disease and Parkinson's Disease Comorbidity
Inga Peter · Icahn School of Medicine at Mount Sinai · funded by Michael J. Fox Foundation for Parkinson's Research
2017–2022 · research · R01
Mapping the role of long noncoding RNAs in gene regulatory networks in schizophrenia
Dalila Pinto · Icahn School of Medicine at Mount Sinai · funded by National Institutes of Health
2017–2021 · research · R01
Ga68-DOTATATE PET imaging of plaque inflammation
Zahi A. Fayad · Icahn School of Medicine at Mount Sinai · funded by National Institutes of Health
2017–2022 · cooperative agreement · UM1
Mount Sinai's COFAR Clinical Research Unit and Clinical Trial (The "ADVANCE" Trial).
Scott H Sicherer · Icahn School of Medicine at Mount Sinai · funded by National Institutes of Health
2017–2020 · research · R21
Sensory consequences of action in children with autism spectrum disorders
Jennifer Foss-Feig · Icahn School of Medicine at Mount Sinai · funded by National Institutes of Health
2017–2023 · career development · K23
Prenatal PM2.5 and programming of respiratory outcomes: Placental biomarkers and effect modification by stress
Alison G Lee · Icahn School of Medicine at Mount Sinai · funded by National Institutes of Health
2017–2029 · research · R01
Characterization of vascular responses to intravitreal anti-VEGF injections in diabetic retinopathy
Yuen Ping Toco Chui · Icahn School of Medicine at Mount Sinai · funded by National Institutes of Health
2017–2022 · research · R01
Prediction of portal pressure with liver and spleen MR Elastography and 4D flow phase-contrast MRI
Bachir Taouli · Icahn School of Medicine at Mount Sinai · funded by National Institutes of Health
2017–2022 · research · R01
Cell Specificity of the Human Heroin Epigenome
Stella Dracheva · Icahn School of Medicine at Mount Sinai · funded by National Institutes of Health
2017–2020 · research · R21
Anti-drug Conjugates That Target Human Cytomegalovirus Infected Cells
Domenico Tortorella · Icahn School of Medicine at Mount Sinai · funded by National Institutes of Health
2017–2023 · cooperative agreement · UH3
Electrophysiological Biomarkers to Optimize DBS for Depression
Helen S Mayberg · Icahn School of Medicine at Mount Sinai · funded by National Institutes of Health
2017–2022 · research · R01
Epigenetic and microenvironmental regulation of dormant disseminated cancer
Julio A. Aguirre-Ghiso · Icahn School of Medicine at Mount Sinai · funded by National Institutes of Health
2017–2022 · research · R01
MicroRNAs in schizophrenia
Paul J. Kenny · Icahn School of Medicine at Mount Sinai · funded by National Institutes of Health
2017–2020 · research · R00
Regulation of hippocampal plasticity and learning and memory by a bloodborne rejuvenation factor
Joseph Michael Castellano · Icahn School of Medicine at Mount Sinai · funded by National Institutes of Health
2017–2022 · cooperative agreement · U01
North East Consortium for Transplant outcomes in APOL1 kidney Recipients (NECTAR) Clinical Center
Darshana Dadhania · Icahn School of Medicine at Mount Sinai · funded by National Institutes of Health
